AB 921 Wisconsin Assembly · 2025-2026 Regular Session

Relating to: cost-sharing cap on insulin.

AB 921 establishes a $35 monthly cap on out-of-pocket costs for insulin under disability insurance policies and self-insured health plans. It directly affects people with diabetes who rely on these specific insurance types for insulin coverage. The bill prohibits insurers from charging more than $35 for a one-month supply of insulin, covering all cost-sharing elements like deductibles and copays. This policy change applies to existing coverage requirements without altering other insurance benefits or mandates. The bill is pending in the 2026 Wisconsin Legislature.
Bill status failed 1 of 4 stages cleared
Introduction
Jan 2026
Committee Review
Floor Vote
Governor
Introduced Jan 28, 2026 Last action Mar 23, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
8
Key actions
0
Committee
0
Jan 28, 2026
Introduced
Introduced by Representatives Billings, Arney, Clancy, DeSmidt, Goodwin, Joers, Miresse, Moore Omokunde, Neubauer, Prado, Roe, Sinicki, Snodgrass, Spaude, Stubbs and Udell; cosponsored by Senators Pfaff, Dassler-Alfheim, Hesselbein, Ratcliff, Roys, Smith, Spreitzer, Wall, Wirch and Larson
lower
16 primary · 0 co-sponsors

Sponsors